Tirzepatide works on two hormonal pathways (GLP-1 and GIP) compared to semaglutide one pathway (GLP-1 only), which clinical data suggests may produce greater weight loss
It is about blood pressure, blood sugar, cholesterol, fatty liver, sleep apnea, mobility, cardiovascular risk, and quality of life
Concerns and Seeking Help: Recognizing signs of problematic drinking is essential
The long-term effects of GLP-1 receptor agonists on hormonal health are still under investigation
The FDA issued warning letters to telehealth sellers over GLP-1 marketing in 2026, so before you buy it is worth confirming a few things on each provider's own site: LegitScript-certified pharmacy Signals the pharmacy meets safety and licensing standards